Venus Medtech (Hangzhou) Inc.

HK$1.03As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2500Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (25.85%)
Medical Devices
Beta (5Y) 1.22
PE TTM —
TSR TTM (62.41%)
Mkt cap HK$451.0M
ROIC (11.04%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.25
20.88%
(18.53%)
Hold 12|10|4|9|10
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.01
0.01
0.02
0.02
5.40%
19.81%
19.01%
20.22%
Revenue¥M
27.47
27.78
28.77
29.63
0.76%
(0.58%)
(0.68%)
5.38%
Peers (US$57.53M)
Cap (US$)
PE
45.53M
—
57.54M
—
Capital
TTM
5Y
10Y
Leveragex
0.111
0.917
0.746
EBIT/Intx
1.040
0.227
0.208
Own earn%
(50.61)
(32.32)
(28.96)
Sh yield%
32.08
14.77
15.61
Owners
Insiders/Inst%
9.33
55.12
Short interest%
2.12
SBC / revenue%
0.90
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
24–35
$1 testx
—
Incr. ROIC%
4